Us Compounding Pharmacies Market

Compounding Pharmacies Market: U.S. Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028

  • 2019-05-09
  • REP-US-978
  • 7 Tables
  • 23 Figures
  • 81 pages
  • PDF PPT EXCEL
Us Compounding Pharmacies Market
  • SELECT LICENSE :

  • US$3,500
  • US$4,500
  • US$7,000

US Compounding Pharmacies – The One Stop Solution for Personalized Drugs

Rising demand for personalized medications is a key factor spurring revenues of US compounding pharmacies. The ‘made from scratch’ factor is one of the key factors enhancing the visibility of compounding pharmacies in the US. The medications prepared in compounding pharmacies are prepared by blending of ingredients as per the desired strength and dosage, which makes them ideal for addressing issues of optimal drug usage. The core value, which is developing tailor-made drugs to cater to patients’ needs, is one of the key aspects fostering popularity of US compounding pharmacies.

In-depth Opinion - Us Compounding Pharmacies Market

US Compounding Pharmacies Market: Key Research Findings

  • FMI forecasts that the U.S. compounding pharmacies market is expected to reach around US$ 14 Bn by the end of 2028.

  • The U.S. compounding pharmacies market is projected to grow with a CAGR of nearly 5% over the forecast period of 2018-2028.

  • Based on product type, the oral medication and topical medication segments are among the prominent segments. They are estimated to collectively gain a revenue share of around 60% over the forecast period.

  • The oral medications segment is expected to witness stable growth over the forecast period owing to the expiry of blockbuster drugs, increase in the levels of experimentation in drug repackaging, and the creation of multiple ingredient combination drugs.

  • By pharmacy type, the 503A pharmacy segment is estimated to gain a higher share as compared to the 503B pharmacy segment. The 503A pharmacy segment of the U.S. compounding pharmacies market is estimated to gain a share of more than 70% throughout the forecast period.

  • Among all the therapeutic areas, hormone replacement therapy and pain management are among the prominent segments of the U.S. compounding pharmacies market, and these segments are expected to collectively gain a revenue share of more than 55% in 2019.

  • Among the application segments, the veterinary segment of the U.S. compounding pharmacies market is expected to witness significant growth with a CAGR of almost 6%, as compared to the other segments.

us_compounding_pharmacies_market

Top 3 Factors Impacting the Growth of the Compounding Pharmacies Market

  1. Growing demand for HRT drugs

The growing popularity of HRTs due to the availability of APIs in varying dosages is driving the growth of the U.S. compounding pharmacies market for compounded HRT drugs. The U.S. compounding pharmacies market is more prominent in the West Coast of the U.S. The key active pharmaceutical ingredients that are currently in demand in the HRT market include progesterone, estradiol, estrogen, and testosterone.

Of late, bio-identical hormone replacement therapies are also driving the U.S. compounding pharmacies market as an increasing number of people in the U.S. strive to defy the aging process. Moreover, the demand for customised hormone replacement therapies has increased in the recent past as people have become more conscious about important health functions such as breast and bone health, sexual health, osteoporosis, depression, etc. 

Accordingly, the dosage requirements for specific customised solutions have increased the demand for hormones such as progesterone after procedures such as hysterectomy, testosterone replacement after andropause, infertility curing hormones, etc. These therapies are expensive and in high demand owing to rapid aging in younger people due to lifestyle changes and increasing stress levels, which is driving the revenue growth of the U.S. compounding pharmacies market.

  1. Upsurge in the demand for topical products

The growing popularity of compounded creams and gels, which comprises ~80% of the topical application category, is driving the growth of the U.S. compounding pharmacies market. Claims from compounding pharmacies for discovering age-defying solutions are increasing substantially.

For example, the average value of a topical compound application prescription has increased from US$ 90 in 2012 to US$ 1,000 in 2014, according to the California State Pharmacy Board, which is one of the prominent market drivers of the U.S. compounding pharmacies market.

  1. Traditional compounding pharmacies operate without FDA’s supervision

Traditional compounding pharmacies, also known as ‘503A compounding pharmacies,’ are is regulated by the State Boards of Pharmacy in the U.S. The standards set by the United States Pharmacopoeia (USP) have to be integrated into the day-to-day pharmacy compounding practice and are mandated by law in most states.

They are mostly used in the off-label production of branded prescription equivalents and can be produced under a patient prescription, which include cases of discontinued drugs, which are still in demand, treatments that require tailored dosages, a combination of multiple APIs into one formulation, etc. Traditional compounding pharmacies are mostly found within smaller towns and communities where the presence of large retail pharmacies is limited.

Compounding Pharmacies Market: Competitive Analysis

  • Leading medical & pharmaceutical companies are collaborating with small compounding solution providers, hospitals, and research facilities to strengthen their market position and create sustainable positioning.

  • Companies in the U.S. compounding pharmacies market are mainly focusing on geographic expansion and the usage of newer equipment according to the customer needs to gain a larger market share.

  • Key players are focusing on strengthening their position by collaborating with local hospitals to enhance their distribution networks.

Market's Future Looks Bright Over Next 9 Years

Compounding pharmacies are gathering significant momentum, on account of rising demand for ‘made-to-order’ medications offering exceptional benefits for specific patients, unlike commercially available drugs. Over the past few years, there has been a significant escalating footfall in compounding pharmacies, wherein patients seek effective medications to fulfill their personal needs. Owing to specific cases of drug shortage in general pharmacy stores, compounding pharmacies is emerging as a viable option for purchasing individualized medicines.

Consumers Depict Bias in Favor of Oral Medications

Compounding pharmacies will continue to receive multiple number of orders placed for oral and liquid medication varieties, such as capsules, tablets, lozenges, mixtures, syrup, solutions, and emulsions. However, demand for topical medications is likely to witness strong growth, given that topical medications find extensive use for a wide-range of applications.

* This data is only a representation. Actual data may vary and will be available in report.

Consumers Depict Bias in Favor of Oral Medications
Consumers Depict Bias in Favor of Oral Medications
Consumers Depict Bias in Favor of Oral Medications
Consumers Depict Bias in Favor of Oral Medications
  • 2014
  • 2018
  • 2022
  • 2028
  • Arrow

Manufacturers in the US compounding pharmacies market are focusing on offering specialty pharmaceutical solutions that are highly affordable, which is a distant move away from what generic pharmacies can provide. In addition, companies operating in the US compounding pharmacies space are also focusing on offering additional advantages over their competitors, such as free shipping and delivery and exclusive deals, with an objective of exceeding customer experiences.

Revenues from 503A pharmacy segment to continue on an upswing

503B pharmacy to emerge as the fastest-growing compounding pharmacy type

Non-sterile techniques to continue as the widely-practiced technique

Use of sterile techniques to grow at an exponential rate, estimated to account for over 24% share by 2028

Compounding pharmacies to see surge in orders placed for adults

Veterinary to be the fastest-growing application type

How Growth will Unfold

Compounding pharmacies are witnessing substantial increase in revenues, both from in-store footfall and shipment orders. Adoption of medications from compounding pharmacies for oncology will continue to gain significant traction, followed by dental and dermatology.

Oncology | Dental | Dermatology

Us Compounding Pharmacies Market Us Compounding Pharmacies Market Us Compounding Pharmacies Market

* This data is only a representation. Actual data may vary and will be available in report.

Click Here To Know How The Growth Will Unfold

Custom Market Research Services

FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Overview

Compounding Pharmacies Market: U.S. Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028

A recent market study published by FMI “Compounding Pharmacies Market: U.S. Industry Analysis 2013-2017 & Forecast 2018-2028” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the compounding pharmacies market, the growth prospects of the market are obtained with maximum precision.

Us Compounding Pharmacies Market Taxonomy

The U.S. compounding pharmacies market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.

By Product Type

  • Oral Medication
    • Solid Medication
      • Capsules
      • Tablets
      • Mixtures
      • Lollipops
      • Lozenges
    • Liquid Medication
      • Syrup
      • Solution
      • Emulsion
      • Suspension
  • Topical Medication
    • Gels
    • Ointments
    • Creams
    • Lotions
  • Injectables
  • Mouthwashes
  • Nasal
  • Ocular
  • Otic
  • Suppositories and Enemas

By Pharmacy Type

  • 503A Pharmacy
  • 503B Pharmacy

By Application

  • Adults
  • Pediatrics
  • Geriatrics
  • Veterinary

By Therapeutic Area

  • Hormone Replacement Therapy
  • Pain Management
  • Dermatology
  • Oncology
  • Hematology
  • Dental
  • Others

By Sterility Type

  • Sterile
  • Non-Sterile

What's Included

The report commences with the executive summary of the compounding pharmacies market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the compounding pharmacies market.

Readers can find the detailed taxonomy and the definition of the compounding pharmacies market in this chapter, which will help them understand the basic information about the compounding pharmacies market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the compounding pharmacies market report.

This chapter explains the key macro-economic factors that are expected to influence the growth of the compounding pharmacies market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the compounding pharmacies market. This chapter also highlights the key market dynamics of the compounding pharmacies market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the compounding pharmacies market.

This section includes the key inclusions of the report. It includes key regulations by FDA, comparative analysis of 503A and 503B pharmacies, and PESTLE Analysis.

This section explain the U.S. market value analysis and forecast for the compounding pharmacies market between the forecast periods of 2013-2028 is highlights in this section. This chapter includes the detailed analysis of the historical compounding pharmacies market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year, and an incremental opportunity for the forecast period (2018 – 2028).

Based on product type, the compounding pharmacies market is segmented into oral medication, topical medication and other. In this chapter, readers can find information about the key trends and developments in the compounding pharmacies market and market attractiveness analysis based on the product type.

This chapter provides details about the compounding pharmacies market on the basis of pharmacy type, and has been classified into 503A pharmacy and 503B pharmacy. In this chapter, readers can understand the market attractive analysis based on pharmacy type.

This chapter provides details about the compounding pharmacies market on the basis of sterility, and has been classified into sterile and non-sterile. In this chapter, readers can understand the market attractive analysis based on sterility.

This chapter provides details about the compounding pharmacies market on the basis of application, and has been classified into adult, pediatric, geriatric, and veterinary. In this chapter, readers can understand the market attractive analysis based on application.

This chapter provides details about the compounding pharmacies market on the basis of therapeutic area, and has been classified into HRT, pain management, dermatology, oncology, hematology, dental, others. In this chapter, readers can understand the market attractive analysis based on therapeutic area.

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Compounding Pharmacies market, along with detailed information about each company, which includes the company overview, revenue analysis, product overview, and analyst commentary. Some of the market players featured in the report are Avella Specialty Pharmacy, Avella Specialty Pharmacy, Hoye’s Pharmacy, Hoye’s Pharmacy, Smith Caldwell Drug Store, Smith Caldwell Drug Store, AIS HealthCare, Soleo Health, Doughertys Pharmacy.

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the compounding pharmacies report.

This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the compounding pharmacies market.

How the research was conducted?

Primary Research

  • C - Level Executives
  • Marketing Directors
  • Sales Heads
  • Pharmacist
  • Physicians
  • Medical Officers
  • Drug Development Heads
  • Strategy Advisors
  • R&D Managers
  • Product Manufacturers
  • Distributors
  • Pharmacists / Pharmacy Benefit Managers
  • Hospital Purchasing Departments
  • Physicians / Nursing Managers
  • Industry Experts
  • Current Market Dynamics and Challenges
  • Market Characteristics
  • Market Performance and Growth Quadrants
  • Competition Structure and Market Structure
  • Strategic Growth Initiatives
  • Disease Patterns, Treatment and Prescription Patterns
  • Regulatory Landscape
  • Near-term and Long-term Market Growth Prospects
  • Market Segment Splits and Authenticity
  • Opinions on Market Projections and Validity of Assumptions

Secondary Research

  • Industry Magazines
  • American Pharmacists Association
  • Professional Compounding Center of America
  • Accreditation Commission for Health Care
  • CompoundingPharmacies.org
  • Factiva
  • Company Press Releases
  • Annual Reports and Investor Presentations
  • Peer-reviewed Journals
  • Government Websites and Publications
  • Trade Websites
  • Clinical Trial Registries
  • Country-specific Regulatory Authorities
  • World Bank, WHO, IMF, OECD
  • Industry Magazines
  • American Sports Medicine Institute
  • American Academy of Orthopedic Surgeons
  • Asia Pacific Orthopedic Association
  • National Center for Biotechnology Information
  • Knee Society
  • Factiva
  • Company Press Releases
  • Annual Reports and Investor Presentations
  • Peer-reviewed Journals
  • Government Websites and Publications
  • Trade Websites
  • Clinical Trial Registries
  • Country-specific Regulatory Authorities
  • World Bank, WHO, IMF, OECD
  • Industry Journals
  • Annual Reports/SEC filings
  • Investor Presentations/Earning Call Transcript

Primary Interview Splits

Primary Research Interview Splits

Us Compounding Pharmacies Market Reports - Table of Contents

Figure 01: U.S. Compounding Pharmacies Market Value Analysis (US$ Mn), 2013-2017

Figure 02: U.S. Compounding Pharmacies Market Value Forecast (US$ Mn), 2018-2028

Figure 03: U.S. Compounding Pharmacies Market Absolute $ Opportunity, 2018 - 2028

Figure 04: U.S. Compounding Pharmacies Market Value Share Analysis (%), By Product Type, 2018 (E)

Figure 05: U.S. Compounding Pharmacies Market Y-o-Y Analysis (%), By Product Type, 2018 -2028

Figure 06: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Product Type

Figure 07: U.S. Compounding Pharmacies Market Attractiveness Analysis by Product Type, 2018-2028

Figure 08: U.S. Compounding Pharmacies Market Value Share Analysis (%), By Pharmacy Type, 2018 (E)

Figure 08: U.S. Compounding Pharmacies Market Y-o-Y Analysis (%), By Pharmacy Type, 2018 -2028

Figure 10: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Pharmacy Type

Figure 11: U.S. Compounding Pharmacies Market Attractiveness Analysis by Pharmacy Type, 2018-2028

Figure 12: U.S. Compounding Pharmacies Market Value Share Analysis (%), By Sterility, 2018 (E)

Figure 13: U.S. Compounding Pharmacies Market Y-o-Y Analysis (%), By Sterility, 2018 -2028

Figure 14: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Sterility

Figure 15: U.S. Compounding Pharmacies Market Attractiveness Analysis by Sterility, 2018-2028

Figure 16: U.S. Compounding Pharmacies Market Value Share Analysis (%), By Application, 2018 (E)

Figure 17: U.S. Compounding Pharmacies Market Y-o-Y Analysis (%), By Application, 2018 -2028

Figure 18: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Application

Figure 19: U.S. Compounding Pharmacies Market Attractiveness Analysis by Application, 2018-2028

Figure 20: U.S. Compounding Pharmacies Market Value Share Analysis (%), By Therapeutic Area, 2018 (E)

Figure 21: U.S. Compounding Pharmacies Market Y-o-Y Analysis (%), By Therapeutic Area, 2018 -2028

Figure 22: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Therapeutic Area

Figure 23: U.S. Compounding Pharmacies Market Attractiveness Analysis by Therapeutic Area, 2018-2028

Table 01: 503A and 503B Pharmacy Comparative Analysis

Table 02: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Product Type (1/2)

Table 03: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Product Type (2/2)

Table 04: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Pharmacy Type

Table 05: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Sterility

Table 06: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Application 

Table 07: U.S. Compounding Pharmacies Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Therapeutic Area 

To Learn More About our Comprehensive Perspective on Us Compounding Pharmacies Market,

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Client Partner - Global Business Development

* indicates mandatory fields

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Methodology